VTXPF (Victrex) 3-Year EBITDA Growth Rate: -17.80% (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

VTXPF Victrex PLC VTXPF
70 GF Score
Price $9.12
GF Value $14.71
Valuation Significantly Undervalued
! 10 Warning Signs
View Full Analysis

What is Victrex 3-Year EBITDA Growth Rate?

Victrex VTXPF 70 3-Year EBITDA Growth Rate is -17.80% as of Mar. 2026. GuruFocus rates VTXPF with a GF Score™ of 70/100 and a GF Value™ of $14.71 (Significantly Undervalued). The stock has 10 warning signs investors should review. Among 1,408 Chemicals companies, Victrex ranks worse than 78.91% on this metric.

Victrex's EBITDA per Share for the six months ended in Mar. 2026 was $-0.46.

During the past 12 months, Victrex's average EBITDA Per Share Growth Rate was -99.60% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was -17.80% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was -11.90% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was -7.60% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of Victrex was 44.00% per year. The lowest was -25.10% per year. And the median was 6.20% per year.


Victrex  (OTCPK:VTXPF) 3-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.


Victrex 3-Year EBITDA Growth Rate Related Terms


VTXPF vs LIN, SHW, ECL: 3-Year EBITDA Growth Rate Comparison

For the Specialty Chemicals subindustry, Victrex's 3-Year EBITDA Growth Rate, along with its competitors' market caps and 3-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Victrex 3-Year EBITDA Growth Rate vs Chemicals Industry

For the Chemicals industry and Basic Materials sector, Victrex's 3-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where Victrex's 3-Year EBITDA Growth Rate falls into.


VTXPF
70GF Score
Victrex PLC VTXPF
3-Year EBITDA Growth Rate is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Victrex 3-Year EBITDA Growth Rate Calculation

This is the 3-year average growth rate of EBITDA per Share. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

What does a 3-Year EBITDA Growth Rate of -17.80% mean?
Victrex (VTXPF) has a 3-Year EBITDA Growth Rate of -17.80% as of Mar. 2026. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Victrex and its competitors. According to the industry distribution chart, Victrex ranks #1111 out of 1408 companies in the Chemicals industry, placing it in the top 78.9%.
Is Victrex's 3-Year EBITDA Growth Rate too high?
Victrex's current 3-Year EBITDA Growth Rate is -17.80%. Based on the distribution chart, Victrex ranks #1111 out of 1408 companies in the Chemicals industry, which is in the bottom quartile relative to peers. Overall, Victrex has a GF Score™ of 70/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Victrex's 3-Year EBITDA Growth Rate compare to LIN and SHW?
According to the Chemicals industry distribution chart, Victrex ranks #1111 out of 1408 companies for 3-Year EBITDA Growth Rate. This places Victrex in the lower half of its industry. The industry median 3-Year EBITDA Growth Rate is 0.80. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 3-Year EBITDA Growth Rate for a Chemicals company?
The median 3-Year EBITDA Growth Rate among Chemicals companies is 0.80, based on 1,408 companies in the industry. Companies in the top quartile (top 25%) have a 3-Year EBITDA Growth Rate significantly above this median, while those in the bottom quartile fall well below. However, 3-Year EBITDA Growth Rate should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 3-Year EBITDA Growth Rate mean?
A high 3-Year EBITDA Growth Rate can signal that a stock is expensive relative to its fundamentals. 3-Year EBITDA Growth Rate is the 3-year average growth rate of EBITDA per share. View historical data for Victrex and its competitors. For the Chemicals industry, the median 3-Year EBITDA Growth Rate is 0.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Victrex's current 3-Year EBITDA Growth Rate is -17.80%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Victrex stock overvalued right now?
Based on GuruFocus' analysis, Victrex (VTXPF) is currently considered Significantly Undervalued. The stock's GF Value™ is $14.71, compared to a current price of $9.12 — trading 38% below its estimated fair value. The current 3-Year EBITDA Growth Rate is -17.80%. Victrex's overall GF Score™ is 70/100 with 10 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 3-Year EBITDA Growth Rate calculated?
3-Year EBITDA Growth Rate is calculated from a company's financial statements. For Victrex (VTXPF), the current 3-Year EBITDA Growth Rate is -17.80% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Victrex (VTXPF) Overvalued in 2026?

Based on GuruFocus' analysis, Victrex stock appears to be undervalued. The current stock price of $9.12 is trading 38% below its estimated GF Value™ of $14.71. GuruFocus considers Victrex to be Significantly Undervalued.

Key valuation signals for VTXPF:

  • 3-Year EBITDA Growth Rate: -17.80%
  • GF Value™: $14.71 vs. price of $9.12 (38% below fair value)
  • GF Score™: 70/100 with 10 warning signs

No single metric tells the full story. See the VTXPF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Victrex Business Description

Other Exchanges VCTl:UKVCT:UK1OY:Germany
Address Victrex Technology Centre, Hillhouse International, Thornton Cleveleys, Lancashire, GBR, FY5 4QD
Victrex PLC is a British specialty chemicals company whose business is based predominantly on manufacturing and creating solutions using polyetheretherketone, or PEEK, an ultra-high-performance lightweight plastic. The business has two segments. The Sustainable Solutions targets transportation, energy, electronics, and manufacturing, while the Medical Segment provides healthcare solutions for the implantable device markets. Geographically operates in the United Kingdom, Europe, the Middle East and Africa (EMEA), America, and Asia-Pacific. Its maximum sales are generated from the Middle East and Africa (EMEA).
70GF Score

Get the complete analysis for VTXPF

3-Year EBITDA Growth Rate is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$9.12
Price
$14.71
GF Value